Senior PharmacologistUS FDASilver Spring, Maryland, United States
Hitching a Ride to Transduce Barriers: Nonclinical Safety Considerations for Developing Transcriptome Modulating Therapies (S08)
Tuesday, November 19, 20249:00 AM – 12:00 PM CT
Targeted Delivery of Oligonucleotides with Antibody or Peptide Conjugates: An FDA Perspective (S08-2)
Tuesday, November 19, 20249:10 AM – 9:40 AM CT